Cargando…
SUN-354 Quality of Life in Patients with Primary Macronodular Adrenal Hyperplasia
Background: The majority of patients with Cushing’s syndrome (CS) have physical and psychological symptoms that may lead to impaired quality of life (QoL). QoL improving with treatment but remaining significantly impaired compared with the general population despite long-term remission. Aim of this...
Autores principales: | Charchar, Helaine, Brondani, Vânia, Ferreira, Amanda, Campanholo, Kenia, Ribeiro, Elyse, Fragoso, Maria, Verduguez, Elisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553354/ http://dx.doi.org/10.1210/js.2019-SUN-354 |
Ejemplares similares
-
SUN-382 Heterogeneous Clinical Presentation In Familial Cases Of Primary Macronodular Adrenal Hyperplasia (PMAH): The Influence Of Somatic Event Of ARMC5.
por: Brondani, Vânia, et al.
Publicado: (2019) -
SUN-390 A Rare Case of Bilateral Macronodular Adrenal Hyperplasia Discovered Incidentally
por: Penaherrera, Carlos, et al.
Publicado: (2019) -
SUN-351 Are We Underestimating The Role Of Systemic Chemotherapy In The Treatment Of Localized And Advanced Adrenocortical Carcinoma?
por: Ferreira, Amanda, et al.
Publicado: (2019) -
Primary Macronodular Adrenal Hyperplasia Associated With Autosomal Dominant ARMC5 Mutation
por: Kerut, Sarah Elizabeth, et al.
Publicado: (2021) -
SUN-180 A Case of Deoxycorticosterone-Producing Malignant Adrenocortical Tumor
por: Cartolano, Natasha Scaranello, et al.
Publicado: (2020)